Drugs / PF-03382792
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01089738 | Nov 2010 → Apr 2011 | — | Pfizer | Withdrawn | No outcome recorded |
| Phase 1 | NCT01045863 | Feb → Jun 2010 | — | Pfizer | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-03382792 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01089738 ↗ |
| Modality | Small molecule | — CHEMBL2179582 ↗ |
| Route | Oral | “Single oral ascending dose of PF-03382792, formulated in solution.” NCT01045863 ↗ |